Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Dividends Paid - Common (2022 - 2025)

Iradimed (IRMD) has disclosed Dividends Paid - Common for 4 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Dividends Paid - Common rose 13.79% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.4 million, a 28.78% decrease, with the full-year FY2024 number at $13.7 million, up 3.44% from a year prior.
  • Dividends Paid - Common was $2.2 million for Q3 2025 at Iradimed, roughly flat from $2.2 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $13.2 million in Q1 2023 to a low of $1.9 million in Q2 2024.
  • A 4-year average of $5.1 million and a median of $2.2 million in 2025 define the central range for Dividends Paid - Common.
  • Biggest YoY gain for Dividends Paid - Common was 13.79% in 2025; the steepest drop was 72.9% in 2025.
  • Iradimed's Dividends Paid - Common stood at $12.6 million in 2022, then grew by 5.29% to $13.2 million in 2023, then crashed by 85.62% to $1.9 million in 2024, then increased by 13.74% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Dividends Paid - Common are $2.2 million (Q3 2025), $2.2 million (Q2 2025), and $2.2 million (Q1 2025).